aTyr Pharma (ATYR)
(Delayed Data from NSDQ)
$5.22 USD
+0.20 (3.98%)
Updated Aug 5, 2025 04:00 PM ET
Pre-Market: $5.16 -0.06 (-1.15%) 9:12 AM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
aTyr Pharma, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ATYR 5.22 +0.20(3.98%)
Will ATYR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ATYR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ATYR
Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year?
EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Lags Revenue Estimates
ATYR: What are Zacks experts saying now?
Zacks Private Portfolio Services
C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Tops Revenue Estimates
Other News for ATYR
aTyr Pharma management to meet with Cantor Fitzgerald
aTyr Pharma management to meet with Cantor Fitzgerald
Bearish Options Activity Observed in aTyr Pharma (ATYR)
aTyr Pharma Inc put volume heavy and directionally bearish
aTyr Pharma management to meet with Cantor Fitzgerald